Familial Mediterranean Fever
Familial Mediterranean Fever
Familial Mediterranean Fever (FMF)
What is FMF?
Familial Mediterranean Fever (FMF) is a rare genetic disorder that affects the immune system. It is characterized by recurring episodes of fever and inflammation in various parts of the body.
Symptoms
- Fever: high temperature, often accompanied by chills or sweating
- Abdominal pain: severe pain in the abdomen, which can be mistaken for appendicitis or other conditions
- Arthritis: joint inflammation and pain, particularly in the knees, ankles, and elbows
- Pericarditis: inflammation of the sac surrounding the heart (pericardium)
- Nephritis: kidney inflammation, which can lead to kidney damage or failure if left untreated
Diagnosis
To diagnose FMF, your doctor may perform the following tests:
- Complete Blood Count (CBC): measures various components of blood, including red and white blood cells, platelets, and hemoglobin
- Erythrocyte Sedimentation Rate (ESR): measures how quickly red blood cells settle at the bottom of a test tube, indicating inflammation levels
- C-Reactive Protein (CRP): measures protein levels in the blood, which rise during inflammation
Treatment of Familial Mediterranean Fever
Gold Standard Treatment: Colchicine
Colchicine is the gold standard treatment for Familial Mediterranean Fever (FMF). It works by inhibiting microtubule polymerization, which leads to a decrease in neutrophil migration and activation. This results in reduced inflammation and pain associated with FMF attacks.Alternatives to Colchicine
- Biologics (e.g., Tocilizumab)
- Steroids
- Immunosuppressants
- Treatment with colchicine should be started at the first sign of an FMF attack.
- The dosage of colchicine may need to be adjusted based on individual patient response.
- Biologics, steroids, and immunosuppressants may have side effects and require careful monitoring. Medical Disclaimer: This information is intended for medical professionals only. Treatment decisions should be made on a case-by-case basis and in consultation with a qualified healthcare professional.
Tocilizumab is an interleukin-6 receptor antagonist that can be used as an alternative to colchicine. It works by blocking the action of interleukin-6, a cytokine involved in inflammation and immune response.
Glucocorticoids such as prednisone can be used to treat FMF attacks. They work by suppressing the inflammatory response and reducing pain and swelling.
Immunosuppressive agents such as azathioprine or cyclophosphamide may be used in patients who do not respond to colchicine or biologics. These medications work by suppressing the immune system's response and reducing inflammation.
Important Considerations
Risk Factors and Causes of Familial Mediterranean Fever
Familial Mediterranean Fever (FMF) is a genetic disorder that affects individuals from Middle Eastern or Mediterranean ancestry. Understanding the risk factors associated with FMF can help identify those at higher risk for developing this condition.
Genetic Predisposition
- The MEFV gene mutation is a known cause of FMF, indicating a strong genetic link to the disease.
- A family history of FMF also increases an individual's risk of developing the condition.
Demographic Risk Factors
- Middle Eastern or Mediterranean ancestry is a significant risk factor for FMF, as this population has a higher prevalence of the MEFV gene mutation.
- The age of onset typically ranges from childhood to adolescence, with most cases presenting during these years.
No Infectious Agent Identified
Unlike many other medical conditions, FMF is not caused by an infectious agent. The exact pathogenesis of the disease remains unclear, but it is believed to be related to genetic mutations affecting the immune system.